U.S. Infrastructure Stock News

NYSE:HAL
NYSE:HALEnergy Services

Halliburton (HAL) Lands Saudi Aramco Contracts For Gas, Oil And Intelligent Fracturing

Halliburton (NYSE:HAL) has secured multi-year contracts from Saudi Aramco covering unconventional gas development and onshore oil activities. The work includes deployment of Saudi Arabia’s first intelligent fracturing platform as part of a major unconventional gas project. The agreements also span a multi-year integrated oilfield program across hundreds of planned wells. Halliburton will expand local manufacturing and workforce commitments to support these projects. For investors watching...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

Fermi (FRMI) Faces A Valuation Test Following Board Exit And $375 Million Notes

Fermi (FRMI) is back in the spotlight after director designee Miles Everson resigned, citing governance concerns around access to board records and how the recent US$375 million convertible notes decision was handled. See our latest analysis for Fermi. Fermi’s governance flashpoint comes after a weak stretch for the stock, with the year to date share price return down 31.41% and the 30 day share price return down 30.14%, while the latest 1 day share price return of 2.02% hints at only...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

Is ArcBest (ARCB) Undervalued Following Its Restructuring And Analyst Upgrades?

ArcBest (ARCB) has moved into focus after announcing a restructuring plan that includes a 2% workforce reduction, the closing of ten ABF Freight service centers, the consolidation of brands, and the booking of sizeable cash charges and non cash impairments. See our latest analysis for ArcBest. The restructuring news comes after a period of strong momentum for ArcBest, with the share price at $159.81 and a 90 day share price return of 34.7%, while the 1 year total shareholder return is...
NYSE:SARO
NYSE:SAROAerospace & Defense

How SunExpress LEAP-1B Deal and MRO Expansion At StandardAero (SARO) Has Changed Its Investment Story

StandardAero, Inc. recently inducted a CFM International LEAP-1B engine for SunExpress, a joint venture of Turkish Airlines and Lufthansa, under a new maintenance, repair and overhaul agreement from its 810,000 sq. ft. San Antonio facility. This step highlights StandardAero’s expanding role as a CFM LEAP Premier MRO provider, with growing LEAP-1A/1B workscopes, industrialized component repairs and an in-house Aviation Mechanic Training Program supporting its engine services...
NYSE:ACN
NYSE:ACNIT

Accenture (ACN) Is Up 6.2% After NATO Cloud Win And New Google AI Suite - Has The Bull Case Changed?

Earlier this month, Accenture announced a roughly €200 million, seven‑year Protected Business Network contract with NATO’s communications agency and unveiled Accenture Edge, a set of Google Cloud–based agentic AI solutions tailored to mid‑market clients. Together, these moves underscore Accenture’s push deeper into secure defense cloud infrastructure and practical AI deployments for organizations that lack large‑enterprise resources. Next, we’ll examine how this NATO cloud contract and...
NYSE:CUZ
NYSE:CUZOffice REITs

Cousins Properties (CUZ) Rallies Toward Fair Value, Is The Stock Fully Priced?

Cousins Properties (CUZ) has drawn fresh attention after recent trading, with the stock closing at $31.76 and showing double digit gains over both the past month and the past three months. See our latest analysis for Cousins Properties. The recent share price move in Cousins Properties builds on stronger momentum, with a 30 day share price return of 14.62% and a 90 day share price return of 31.84%, alongside a 1 year total shareholder return of 18.07%. If recent gains in Cousins Properties...
NasdaqGM:ANIP
NasdaqGM:ANIPPharmaceuticals

ANI Pharmaceuticals (ANIP) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings

ANI Pharmaceuticals has delivered a strong 139.1% return over the past 5 years, yet at around US$79.20 the valuation checks now suggest the stock is closer to fairly priced than obviously cheap. A 139.1% total return over 5 years indicates ANI Pharmaceuticals has already rewarded patient shareholders, so fresh buyers may be weighing how much of the story is reflected in the current price. Positive topline data from the SYNCHRONICITY trial can support expectations for the branded portfolio,...
NasdaqCM:EGBN
NasdaqCM:EGBNBanks

3 U.S. Regional Bank Stocks Most Exposed To Higher Interest Rates

The Fed’s renewed hawkish tone, paired with volatile energy prices and a firm labor market, is reshaping how investors think about interest rate risk. For U.S. regional banks, tighter policy can shift the balance between what they earn on loans and what they pay on deposits, while swings in inflation expectations influence funding costs and credit demand. This article uses a focused screener of mid sized lenders to highlight 3 regional bank stocks whose business profiles could be especially...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Lands Bell Canada Ground Station And New Zealand Approval

Bell Canada has completed its first direct to device satellite ground station to support AST SpaceMobile's network in Canada. AST SpaceMobile secured new regulatory approval in New Zealand, expanding its potential service footprint. The company is preparing for the launch of additional BlueBird satellites to build out its direct to device constellation. AST SpaceMobile (NasdaqGS:ASTS) is back in focus as it adds fresh infrastructure and regulatory pieces to its direct to device puzzle. The...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

DoorDash (DASH) Seeks New Mexico Approval For Dot Delivery Robots

DoorDash (NasdaqGS:DASH) is seeking approval in New Mexico to deploy its autonomous delivery vehicle, Dot, for short-distance deliveries. The company is pursuing legislative changes that would allow these robots to operate on public roads across the state. The outcome could influence how quickly DoorDash rolls out similar technology in additional U.S. jurisdictions. DoorDash is best known for its food delivery platform, and the push to deploy Dot in New Mexico highlights how the company is...
NasdaqGS:EXLS
NasdaqGS:EXLSProfessional Services

ExlService Holdings (EXLS) Draws Valuation Attention, Is The 33% Upside Enough?

ExlService Holdings (EXLS) has come back into focus after recent trading saw the stock close at US$28.16, drawing attention to how its current valuation lines up with its financial profile and market performance. See our latest analysis for ExlService Holdings. Recent trading has been choppy for ExlService Holdings, with the share price falling 1.85% over the last day but rising 3.15% over the past week. The year to date share price return is down 31.67%, and the 1 year total shareholder...
NYSE:PRU
NYSE:PRUInsurance

Prudential Financial (PRU) Shares Sit 15% Above Fair Value On Earnings Beat

Prudential Financial (PRU) is in the spotlight after reporting stronger than expected first quarter earnings, with firmer investment income, solid annuity and retirement demand, and management underscoring ongoing business transformation and retirement focused product expansion. See our latest analysis for Prudential Financial. The stronger first quarter update has arrived alongside a clear pick up in momentum, with Prudential Financial’s 30 day share price return of 11.27% and 90 day share...
NYSE:IDT
NYSE:IDTTelecom

How June’s Same-Store Sales Gain With Softer Volumes Will Impact IDT (IDT) Investors

In early July 2026, NRSInsights reported that IDT’s June 2026 same-store sales rose 3.4% year over year, while units sold fell 1.5% compared to a year earlier. The combination of higher same-store sales but fewer units sold suggests consumers may be purchasing fewer items at higher prices or shifting toward higher-value products, reshaping how IDT’s retail data is interpreted. We’ll now examine how June’s 3.4% same-store sales growth, alongside softer unit volumes, feeds into IDT’s existing...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT) Stock Could Trade At A Discount As Its 346% Run Looms

Corcept Therapeutics has delivered very strong long term share price gains over the past five years, yet its latest valuation checks lean more cautious, leaving investors weighing a powerful performance track record against a weak overall value score. Corcept Therapeutics is up about 346.1% over five years, which puts the recent share price in the context of a very strong run already behind it. Progress with cortisol modulating drugs, including Lifyorli and the resubmitted relacorilant...
NasdaqGS:VSEC
NasdaqGS:VSECAerospace & Defense

Defense Stocks With Direct Exposure to Energy Security and Military Readiness

Geopolitics just moved back to the front of the market’s attention, with U.S. strikes on Iran, drone and missile attacks across the Gulf, and oil prices reacting sharply. When tensions spill into shipping lanes and supply chains, some stocks can gain new contracts or attention, while others face higher risks and costs. This article looks at how that mix of risk and opportunity connects to the latest Defense and Aerospace Stocks screener and highlights 3 stocks that appear positively exposed...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Is Arrowhead Pharmaceuticals (ARWR) Undervalued Or Is Its Pipeline Promise Already Priced In?

Arrowhead Pharmaceuticals (ARWR) has drawn investor attention after recent share price moves, with the stock up about 4.1% over the past day but down roughly 8.3% over the past month. See our latest analysis for Arrowhead Pharmaceuticals. The recent 1 day share price return of 4.1% comes after a softer 30 day share price return of 8.3% and a 9.6% share price return year to date. The 1 year total shareholder return of very large magnitude suggests Arrowhead Pharmaceuticals has already...
NYSE:DHR
NYSE:DHRLife Sciences

Will Masimo Integration and Bioprocessing Strength Change Danaher's (DHR) Diagnostics-Driven Narrative?

Danaher recently benefited from optimism around its July 21 Q2 2026 earnings release, with analysts expecting modest revenue and earnings growth supported by strength in bioprocessing and filtration, plus contributions from acquisitions like Masimo and Leica Biosystems’ agreement to acquire StatLab Medical Products. Investors are increasingly focused on how these diagnostics-expanding deals and bioprocessing momentum might offset ongoing cost pressures, high debt levels, and softness in...
NYSE:TFC
NYSE:TFCBanks

Truist Financial (TFC) Could Be 6% Undervalued As Earnings Beat Fuels Fresh Valuation Debate

Truist Financial (TFC) is back in focus after reporting second quarter 2026 earnings that topped expectations, outlining higher net income, a refocused lending mix, and continued share buybacks. See our latest analysis for Truist Financial. The share price of Truist Financial has climbed over recent months, with a 30 day share price return of 8.99% and a 1 year total shareholder return of 24.02%. This suggests recent earnings, lending shifts and buybacks are being viewed as supportive. The 3...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

Is Bitdeer (BTDR) Using Its New Nevada Plant To Quietly Recast Its Hardware Strategy?

Bitdeer Technologies Group has broken ground on a new 187,000-square-foot advanced electronics manufacturing facility in Sparks, Nevada, marking a US$36 million move into domestic production of its SEALMINER computing hardware and creating 70 local jobs. This facility, set to augment Bitdeer’s existing U.S. data centers and innovation hub, signals a deeper commitment to U.S.-based, vertically integrated computing hardware manufacturing within Nevada’s growing tech ecosystem. Next, we’ll...
NYSE:ABT
NYSE:ABTMedical Equipment

Abbott Laboratories (ABT) Stock Faces Margin Squeeze As Net Profit Slide Tests Growth Narrative

Abbott Laboratories (ABT) just posted Q2 2026 revenue of about US$12.6b with basic EPS of US$0.53, alongside trailing twelve month revenue of roughly US$46.6b and EPS of US$3.11. Over recent quarters the company has seen revenue move from about US$11.1b in Q2 2025 to US$12.6b in Q2 2026, while quarterly EPS shifted from US$1.02 to US$0.53. This sets up a results season where investors are likely to focus closely on how margins are holding up in the current mix of growth drivers. See our full...
NYSE:KEX
NYSE:KEXShipping

Kirby (KEX) Draws Interest As Tight Barge Supply Supports A Fair Value Gap

AI trading signals put Kirby in focus Fresh AI generated trading signals around Kirby (KEX) have pushed the stock into the spotlight, with the models flagging neutral near and mid term readings, as well as a long term strong positive bias. The same signals highlight a mid channel oscillation pattern and outline a short setup with defined downside potential and limited indicated risk, along with suggested institutional style long, breakout, and hedging approaches. See our latest analysis for...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Palantir Technologies (PLTR) After New AI Deals And Government Wins Looks Fully Valued

Palantir Technologies (PLTR) is back in focus after a series of AI focused partnerships and government wins, including new work with the U.S. Small Business Administration and enterprise clients across insurance and cloud infrastructure. See our latest analysis for Palantir Technologies. Despite the stream of new AI partnerships and government work, Palantir Technologies’ share price has been under pressure, with the stock down 21.14% on a year to date share price return and the 1 year total...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Tesla (TSLA) Stock Looks Strong On Returns But Rich On Sales

Tesla stock is back in focus after a strong multi year run, yet the latest valuation checks suggest the shares are pricing in a lot of good news rather than offering clear value. Over the last 5 years, Tesla has returned about 77.6%, which puts current buyers in a very different position to investors who entered much earlier. Expectations around areas like robotaxis, Optimus and energy storage can support a rich valuation. At the same time, regulatory scrutiny on autonomy and rising...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab Stock And 2 More Penny Shares Backed By Stronger Balance Sheets

Penny stocks often carry a reputation for high risk, but the Financially Fit Penny Stocks screener focuses on companies trading below $5 that also show healthier balance sheets than many early stage peers. With inflation readings, interest rate expectations, and consumer sentiment sending mixed signals across major economies, some investors are looking for smaller stocks where financial discipline is central. This article highlights three stocks from the Financially Fit Penny Stocks screener...